Successful treatment of coccidioidal meningitis with voriconazole

Clinical Infectious Diseases

Volumn 36, Issue 12, 2003, Pages 1619-1622

  Cortez, Karoll J ^a   Walsh, Thomas J ^b   Bennett, John E ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; CEFTRIAXONE; FLUCONAZOLE; MULTIVITAMIN; SUNSCREEN; VORICONAZOLE; ANTIFUNGAL AGENT; PYRIMIDINE DERIVATIVE; TRIAZOLE DERIVATIVE;

ADULT; ARTICLE; BRAIN EDEMA; BRAIN STEM; CASE REPORT; CEREBROSPINAL FLUID; COCCIDIOIDES; COCCIDIOIDOMYCOSIS; CRANIAL NERVE PARALYSIS; DISEASE COURSE; DOSE RESPONSE; DRUG BLOOD LEVEL; HUMAN; INFLAMMATION; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PHOTOSENSITIVITY; PRIORITY JOURNAL; REMISSION; SYMPTOM; TREATMENT FAILURE; FUNGAL MENINGITIS; MIDDLE AGED; TREATMENT OUTCOME;

ANTIFUNGAL AGENTS; COCCIDIOIDOMYCOSIS; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MENINGITIS, FUNGAL; MIDDLE AGED; PYRIMIDINES; TREATMENT OUTCOME; TRIAZOLES;

EID: 0037871889     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/375235     Document Type: Article

References (9)

1. Galgiani JN, Catanzaro A, Cloud GA, et al. Fluconazole therapy for coccidioidal meningitis. Ann Intern Med 1993; 119:28-35.
2. Galgiani JN, Ampel NM, Catanzaro A, Johnson RH, Stevens DA, Williams PL. Practice guidelines for the treatment of coccidioidomycosis. Clin Infect Dis 2000; 30:658-61.
3. Denning DW, Griffith CE. Muco-cutaneous retinoid-effects and facial erythema related to the novel triazole antifungal agent voriconazole. Clin Exp Dermatol 2001; 26:648-53.
4. Drutz DJ, Catanzaro A. Coccidioidomycosis. Part II. Am Rev Resp Dis 1978; 117:727-71.
5. Schwartz S, Milatovic D, Thiel E. Successful treatment of cerebral aspergillosis with a novel triazole (voriconazole) in a patient with acute leukemia. Br J Haematol 1997; 97:663-5.
6. Purkins L, Wood N, Ghahramani P, Greenhalgh K, Allen MJ, Kleinermans D. Pharmocokinetics and safety of voriconazole following intravenous- to oral-dose escalation regimens. Antimicrob Agents Chemother 2002; 46:2546-53.
7. Van Wauwe JP, Coene M-C, Goossens J, van Nijen G, Cools W, Lauwers W. Ketoconazole inhibits the in vitro and in vivo metabolism of all-trans-retinoic acid. J Pharmacol Exp Ther 1988; 245:718-22.
8. Erly WK, Bellon RJ, Seeger JF, Carmody RF. MR imaging of acute coccidioidal meningitis. AJNR Am J Neuroradiol 1999; 20:509-14.
9. Wrobel CJ, Meyer S, Johnson RH, Hesselink JR. MR findings in acute and chronic coccidioidomycosis meningitis. AJNR Am J Neuroradiol 1992; 13:1241-45.